Hosted on MSN1mon
Boston Scientific CFO sells $1.59 million in stockBoston Scientific Corp.'s (NYSE:BSX) Executive Vice President and Chief Financial Officer, Daniel J. Brennan, recently engaged in a series of stock transactions, according to a recent SEC filing.
Hosted on MSN1mon
Boston Scientific remains bullish despite tariffs, with sales buoyed by Minnesota techClimbing sales for a made-in-Minnesota system treating atrial fibrillation helped sustain Boston Scientific ... Chief Financial Officer Daniel Brennan said Wednesday that the company does ...
Boston Scientific Corporation (NYSE ... representing growth of 12% to 14%. Daniel Brennan will provide more details on the financials, and then I'll provide some initial highlights in 2024.
Hosted on MSN1mon
Boston Scientific targets 12%-14% EPS growth for 2025 with strong FARAPULSE and WATCHMAN momentumCFO Daniel Brennan reported Q4 consolidated ... with management affirming adequate capacity to meet growing FARAPULSE demand. Boston Scientific delivered another strong quarter, exceeding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback